Literature DB >> 21426679

[Pleomorphic adenoma of trachea: a report of one patient].

Liang Guo1, Yinping Wang, Hongxi Ma.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21426679      PMCID: PMC5999658          DOI: 10.3779/j.issn.1009-3419.2011.03.19

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


× No keyword cloud information.

病例资料

患者女,2 3岁。因“间断咳血一月余”来我院就诊。一月前因“感冒”后出现咳鲜血(约10 mL)伴发热、咳嗽及咳痰,CT扫描示气管肿物,给予抗炎对症治疗后咳嗽、咳痰症状消失。由外院支气管镜活检,病理诊断为良性肿瘤,于2009年1月5日转入我院进一步诊治。支气管镜检查:主气道距隆突近3 cm处见一肿物突向管腔,管腔明显狭窄。CT扫描见气管下段管腔内一类圆形团块影,边缘较光整,基底部与气管左后壁似有蒂相连。手术袖状切除部分气管及肿物后行气管成形术。 病理检查:送检一段气管,长1.8 cm,直径1.6 cm,距上端切缘0.4 cm处见一肿物,体积2.0 cm×1.2 cm× 1.0 cm,肿瘤位于气管粘膜下,未见明显包膜,表面光滑,切面呈实性,灰白色,镜下见上皮细胞分布在粘液样基质中,上皮细胞呈片状及腺样排列(图 1)。免疫组化显示Ki-67阳性率 < 5%,瘤细胞SMAp63呈阳性表达(图 2)。
1

气管多形性腺瘤的HE染色结果。A:肿物位于气管软骨旁,上皮样细胞在粘液样基质内呈腺样及片状排列(HE, ×40);B:肿物位于气管粘膜下,上皮样细胞在粘液样基质内成片排列(HE, ×100)。

HE stain results of pleomorphic adenoma of trachea. A: The tumor located by bronchial cartilage, glandular and sheets of epitheliod cells scattered in myxoid stroma (HE, ×40); B: Beside the respiratory mucosa sheets of epitheliod cells scattered in the myxoid stroma (HE, ×100).

2

气管多形性腺瘤的免疫组化染色结果。A:Ki-67阳性率 < 5%(IHC, ×200);B:上皮样细胞中SMA呈阳性(IHC, ×200);C:上皮样细胞中p63呈阳性(IHC, ×200)。

Immunohistochemical stain results of pleomorphic adenoma of trachea. A: Positive rate of Ki-67 < 5% (IHC, ×100); B. Expression of SMA in epitheliod cells was positive (IHC, ×100); C. Expression of p63 in epitheliod cells was positive (IHC, ×200).

气管多形性腺瘤的HE染色结果。A:肿物位于气管软骨旁,上皮样细胞在粘液样基质内呈腺样及片状排列(HE, ×40);B:肿物位于气管粘膜下,上皮样细胞在粘液样基质内成片排列(HE, ×100)。 HE stain results of pleomorphic adenoma of trachea. A: The tumor located by bronchial cartilage, glandular and sheets of epitheliod cells scattered in myxoid stroma (HE, ×40); B: Beside the respiratory mucosa sheets of epitheliod cells scattered in the myxoid stroma (HE, ×100). 气管多形性腺瘤的免疫组化染色结果。A:Ki-67阳性率 < 5%(IHC, ×200);B:上皮样细胞中SMA呈阳性(IHC, ×200);C:上皮样细胞中p63呈阳性(IHC, ×200)。 Immunohistochemical stain results of pleomorphic adenoma of trachea. A: Positive rate of Ki-67 < 5% (IHC, ×100); B. Expression of SMA in epitheliod cells was positive (IHC, ×100); C. Expression of p63 in epitheliod cells was positive (IHC, ×200). 病理诊断:气管多形性腺瘤。

讨论

多形性腺瘤多发生于涎腺组织,发生于气管者罕见,文献[报道50余例。此瘤可发生于气管内,也可见于肺实质内。肿瘤直径大小为2 cm-16 cm,多呈息肉样。气管内的病变常累及主支气管或二级支气管,因此表现出阻塞的症状如咳嗽、咳痰、呼吸困难及喘息等。本例患者病变位于气管内,以咳血为首发症状,可能是由于肿瘤侵及血管,导致出血。患者伴有咳嗽、咳痰和感染,与文献[描述一致。位于肺实质内的病变通常不累及气道,因此多无临床症状,常在查体行影像学检查时被发现[。 病理检查:气管多形性腺瘤的组织学改变与发生于唾液腺者相同,具有双向分化特征。片状、小梁状或岛状的上皮细胞和(或)肌上皮细胞分布在粘液样、透明软骨样基质或透明变性间质中。可以伴有灶性鳞状上皮化生和纤维化,间质中也可见脂肪组织及脂肪母细胞[。出现坏死和病理核分裂常提示有恶变的可能,但很少见。免疫组化显示上皮成分CK阳性,肌上皮细胞vimentin、actin及S-100阳性[。本病例切片中,上皮样细胞中p63SMA表达阳性,提示该病例以肌上皮样细胞分化为主。同时Ki-67阳性率 < 5%,显示较低的增殖活性。 多形性腺瘤的发生机制尚不清楚[。诊断时需与类癌、腺样囊性癌、低恶度的粘液表皮样癌、软骨瘤及错构瘤等相鉴别[。 肿瘤切除和气管重建是目前治疗此瘤的主要方法。少数病例术后有转移或复发的报道,故认为生物学行为具有低度恶性潜能[。肿瘤的复发取决于肿瘤的大小、局部的浸润程度以及核分裂[。因此多数学者倾向手术治疗,以防复发。
  5 in total

1.  Pleomorphic adenoma of the trachea.

Authors:  Shigehisa Kajikawa; Masahide Oki; Hideo Saka; Suzuko Moritani
Journal:  Respiration       Date:  2010-04-01       Impact factor: 3.580

Review 2.  Pleomorphic adenoma in the periphery of the lung. Report of a case and review of the literature.

Authors:  H Sakamoto; H Uda; T Tanaka; T Oda; H Morino; M Kikui
Journal:  Arch Pathol Lab Med       Date:  1991-04       Impact factor: 5.534

3.  Pleomorphic adenoma of the trachea in an 8-year-old boy: a case report.

Authors:  Massoud Baghai-Wadji; Mahnoosh Sianati; Hossein Nikpour; Shahriar Koochekpour
Journal:  J Pediatr Surg       Date:  2006-08       Impact factor: 2.545

Review 4.  Tracheobronchial gland tumors.

Authors:  Henning A Gaissert; Eugene J Mark
Journal:  Cancer Control       Date:  2006-10       Impact factor: 3.302

5.  Pleomorphic adenoma with an endobronchial resection.

Authors:  Mikako Matsubara; Masanori Yasuo; Tsuyoshi Tanabe; Kenji Tsushima; Kazuhisa Urushihata; Hiroshi Yamamoto; Masayuki Hanaoka; Tomonobu Koizumi; Keisaku Fujimoto; Keishi Kubo; Yoshitaka Yamazaki; Takeshi Uehara
Journal:  Intern Med       Date:  2008-06-16       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.